& Shah, R
1 At one year, GLP-1 members demonstrated ~2x greater average weight loss than real-world evidence with standard care
Animal studies suggest testosterone may enhance GLP-1 signaling in certain tissues, while human clinical data remain sparse
Fat slows stomach emptying further, which helps keep energy levels steady Dont skip breakfast, even if its small
Timeline of Key Regulatory and Legal Events: September 9, 2025 FDA Warning Letter: The FDA issued a warning letter to Hims & Hers Health on September 9, 2025, finding false or misleading claims on its website about compounded semaglutide and tirzepatide, including phrases such as Same active ingredient as Ozempic and Wegovy and Clinically proven ingredients, which imply the compounded products are the same as FDA-approved drugs when they are not
Other recognised side effects include: Injection site reactions (redness, itching, bruising) Decreased appetite Gallbladder disease (cholelithiasis, cholecystitis) Rare but serious adverse effects that require immediate medical attention include: Pancreatitis (severe, persistent abdominal pain) semaglutide should be discontinued if pancreatitis is suspected Diabetic retinopathy complications (in patients with pre-existing retinopathy) Acute kidney injury (particularly in the context of severe dehydration) Severe allergic reactions (anaphylaxis, angioedema) Patients should be counselled about these potential effects before starting treatment and provided with clear guidance on recognising symptoms that warrant urgent medical review
.png.jpg)
